Showing 861 - 880 results of 107,771 for search '(( 6 e decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.53s Refine Results
  1. 861
  2. 862

    Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer by Alexander Henke (145303)

    Published 2012
    “…Four candidates (Decorin, SPARC, Spry-1, Tsukushi) were immunolocalised in human foetal prostate (weeks 14, 16, 19) and expression of Decorin was evaluated on a human prostate cancer tissue microarray. In embryonic and perinatal rats Decorin, Semaphorin6D, SPARC, Spry-1 and Tsukushi were expressed with varying distribution patterns throughout the mesenchyme at E17.5, E19.5, P0.5 and P6.5. …”
  3. 863
  4. 864
  5. 865
  6. 866
  7. 867

    <i>Ext1</i> mutant lungs exhibit a decrease in SHH-FGF10 signaling. by Hua He (120374)

    Published 2017
    “…<p>(A) qPCR analysis of key components of FGF signaling pathway in lungs from E14.5. …”
  8. 868
  9. 869
  10. 870
  11. 871
  12. 872

    <i>l</i>-THP decreased level of NO, ONOO<sup>−</sup> and iNOS, regulated expression of p85, eNOS and Akt. by Yi Han (194901)

    Published 2013
    “…Serine<sup>473</sup> phosphorylation of Akt was significantly increased in <i>l</i>-THP (M)-treated group, but total Akt expression was not increased, <sup>#</sup>P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 5. (<b>f</b>) Cardiac ONOO<sup>−</sup> generation, as measured by luminol-enhanced chemiluminescence, in each of the five groups, <sup>#</sup>P<0.05 vs. sham group, *P<0.05, **P<0.01 vs. vehicle group, n = 6. …”
  13. 873

    Changes in neural activity were decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants when the worms switched their locomotive direction. by Haruka Mori (8082215)

    Published 2019
    “…<p>(A–F) the neural activity of the RID changes during the transition periods from backward to forward locomotion (A–C) and from forward to backward locomotion (D–F) in the mock (A: p = 1.5 × 10<sup>−5</sup>; D: p = 5.5 × 10<sup>−13</sup>), 5-HT exposed (B: p = 0.092; E: p = 0.79), and <i>mod-1</i> mutant (C: p = 0.081; F: p = 0.93) groups. …”
  14. 874
  15. 875
  16. 876
  17. 877

    Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

    Published 2011
    “…Representative histograms are presented illustrating cells that had a robust decrease in S-phase (NMuMG), modest decrease in S-phase (EpH4), and no decrease in S-phase (MDA-MB-436) as a result of TGF-βtreatment. …”
  18. 878
  19. 879
  20. 880